University of Pittsburgh
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pittsburgh sits in the top decile of US sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count).
University of Pittsburgh: 1,238 sponsored US clinical trials, 160 recruiting.
University of Pittsburgh sponsors 1,238 registered US clinical trials on ClinicalTrials.gov, 160 of them currently recruiting, and 917 completed. 84 of these trials are in Phase 3-4 (later-stage) and 160 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of Pittsburgh ranks in the top decile of sponsors by registered trial count (#22 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
917 of 1,014 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,238 total, page 2 of 25
Imaging Speech in Neurotypical Adults and Individuals With Cerebellar Stroke
NCT06458153
Assessing Improvements in Mood and Sleep Trial
NCT06639477
Transdiagnostic Sleep and Circadian Intervention + Bright Light in Adolescents With Elevated Depression (TranS-C+BL)
NCT06963463
Neuromodulation of Brain and Emotional Responses to Psychological Stress
NCT06603064
Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care
NCT06810076
Get ActivE Study for At-risk Youth
NCT06829953
Teen Brain Online II: Understanding How Social Media Affects the Teen Brain
NCT06817993
Improving PCP Advance Care Planning for People With ADRD
NCT06565169
Cannabis Effects on Sleep, Circadian Rhythms, and Light Sensitivity in Young Adults
NCT06743373
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
NCT06374238
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
NCT06806163
Acceptance and Commitment Therapy Integrated Vestibular Rehabilitation (ACTIVE) RCT
NCT06819904
Enhancing Telemedicine for T2D
NCT06740435
Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study
NCT06540547
Sleep Promotion Program Primary Care
NCT06240325
Centering Gender Affirming Resources in Higher Education
NCT06390332
Feasibility of Resting Intervals During Exercise Programs for Individuals With Knee Osteoarthritis
NCT06857123
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
NCT06643351
Dose-Response to Resistance Exercise on Cardiovascular Health
NCT06619444
Pain Self-Management and Treatment Engagement for Patients Taking Opioids
NCT06855732
Strategy Training for Individuals With Unilateral Neglect
NCT06400147
Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors
NCT06475807
Virtual Peer Coaching in Manual Wheelchair Skills
NCT06295146
Community Resiliency Collective Efficacy Intervention
NCT05768217
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
NCT06296394
Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy
NCT06296147
Liver Volume Variation Effect on SBRT Planning and Delivery for Upper Abdominal Malignancies
NCT06355895
Comparing Two Different Emotion Therapies for Autistic Youth and Young Adults
NCT06158581
Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence
NCT05172089
Testing an Intergenerational Model of Suicide Risk in Mother-child Dyads
NCT06463054
Nicotinamide Riboside in Ulcerative Colitis
NCT05561738
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
NCT06081426
Activity and Participation in Vestibular Disorders
NCT06271694
Adaptive Trial Scheduling in Naming Treatment for Aphasia
NCT05653466
Optimizing Attention and Sleep Intervention Study
NCT05683756
Balancing Effortful and Errorless Learning in Naming Treatment for Aphasia
NCT05653440
Development and Testing of imHere4U: A Digital Suicide Prevention Intervention for Cyberbullied Adolescents
NCT06002191
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
NCT06191484
Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting
NCT04452305
The Metabolic Effects of Intermittent Fasting
NCT05722873
Cerebrovascular Health and Resilience in Midlife
NCT06029348
A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss Program
NCT05748158
Concussion Treatment in Older Adults
NCT05849064
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
NCT05805709
Mobile Health Program for Rural Hypertension
NCT05546931
Functional Recovery After Total Knee Arthroplasty
NCT06821269
Offset Mechanisms in Evaluation of Lumbar Medial Branch Blocks
NCT05961800
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
NCT05655936
Characterization of Gastric Evoked Potentials
NCT05924009
Neuro-affective Response to Light in Depressed Adolescents and Young Adults
NCT05712772
What is open in the University of Pittsburgh pipeline
160 recruiting of 1,238 indexed (13% open); 917 completed (74%).
Phase mix: 84 late (III/IV) vs 160 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Pittsburgh: open-pipeline peers nationwide
Peers matched on 1,238 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Pittsburgh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,238 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Intermountain Health Care · 13% recruiting · 85 trials
- McMaster University · 13% recruiting · 31 trials
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 13% recruiting · 93 trials
- Temple University · 13% recruiting · 163 trials
Related
What to do with this University of Pittsburgh page
1,238 registered trials is a research-attention snapshot, not an endorsement of University of Pittsburgh or any single study.
- 160 of University of Pittsburgh's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Pittsburgh studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Pittsburgh pipeline card: 1,238 registered trials from official public datasets.Report a data error.